Search
for
Sort by
Research 301–330 of 1000+
- Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities
- Emerging Topical and Systemic JAK Inhibitors in Dermatology
- The Rotterdam Study: 2010 objectives and design update
- Dermal β-catenin activity in response to epidermal Wnt ligands is required for fibroblast proliferation and hair follicle initiation
- WNT Signaling in Disease
- What’s Sex Got to Do With COVID-19? Gender-Based Differences in the Host Immune Response to Coronaviruses
- Single-cell RNA-seq highlights heterogeneity in human primary Wharton’s jelly mesenchymal stem/stromal cells cultured in vitro
- PandaOmics: An AI-Driven Platform for Therapeutic Target and Biomarker Discovery
- Unraveling the ECM-Immune Cell Crosstalk in Skin Diseases
- Wnt/β‐catenin pathway in tissue injury: roles in pathology and therapeutic opportunities for regeneration
- Hidradenitis suppurativa: A practical review of possible medical treatments based on over 350 hidradenitis patients
- Extracellular vesicles as human therapeutics: A scoping review of the literature
- Comparison of two ASC-derived therapeutics in an in vitro OA model: secretome versus extracellular vesicles
- Drug repurposing: A novel strategy to target cancer stem cells and therapeutic resistance
- Macrophages in Skin Wounds: Functions and Therapeutic Potential
- 17β-estradiol Inhibits the Production of RANTES in Human Keratinocytes
- Scoping Review on the Use of Drugs Targeting JAK/STAT Pathway in Atopic Dermatitis, Vitiligo, and Alopecia Areata
- Frontiers in alopecia areata pathobiology research
- Mechanical and Immunological Regulation in Wound Healing and Skin Reconstruction
- Engineered extracellular vesicles for tissue repair and regeneration
- Comorbid Conditions Associated with Alopecia Areata: A Systematic Review and Meta-analysis
- Alarmin Cytokines as Central Regulators of Cutaneous Immunity
- S100A6: molecular function and biomarker role
- Lysophospholipid Mediators in Health and Disease
- Evaluating the Therapeutic Potential of Ritlecitinib for the Treatment of Alopecia Areata
- Topical drug delivery strategies for enhancing drug effectiveness by skin barriers, drug delivery systems and individualized dosing
- Folliculin interacts with p0071 (plakophilin-4) and deficiency is associated with disordered RhoA signalling, epithelial polarization and cytokinesis
- Pericyte Plasticity in the Brain
- High-throughput T cell receptor sequencing identifies clonally expanded CD8+ T cell populations in alopecia areata
- Pathomechanisms of immune-mediated alopecia